Examination of the wrinkle improvement effect in the consecutive use of the antiwrinkle product(MAW-1).

UMIN ID: UMIN000038443

Registered date:06/11/2019

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: wrincle
• Date of first enrollment: 2019/11/07
• Target sample size: 30
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Apply quasi drug(MAW-1) 2 times a day for 12 weeks to the outer corner of a half face allocated randomly by assignment director.
Apply placebo cosmetic 2 times a day for 12 weeks to the outer corner of a half face allocated randomly by assignment director.

Outcome(s)

• Primary Outcome: The wrincle depth evaluated by replica of eye area. Wrinkle grade judgment by the Dermatologist.

Key inclusion & exclusion criteria

• Age minimum: 40years-old
• Age maximum: 60years-old
• Gender: Male and Female
• Exclude criteria: 1)Person with chronic skin symptoms such as atopic dermatitis, contact-related dermatitis, skin hypersensitivity 2)Person with the abnormality that is remarkable in the skin state of the face which is a test part 3)The person who receives hormone replacement therapy 4)Person with the experience of beauty medical care affecting the test part 5)The person who I receive special facial care (facial beauty treatment salon P ring laser), and does not pass more than one month 6)The person who takes in the supplement which declared diet or a fair skin effect routinely 7)The extreme person that I tan or work and sports are not avoided outdoors for a long time 8)The person who used pharmaceutical products, an unregulated drug, a supplement, the health food which might have an influence on the final examination regularly 9)Person with a history of the past when I am dangerously ill to heart, liver, a digestive organ 10)An excessive cigarette and an alcohol habitual offender and the person that the eating habits are extremely irregular 11)During the pregnancy or the person who plans the pregnancy all over the person, the study time nursing it 12)In addition, the person who judged that a study person in charge or the study person in charge was ill-qualified

Related Information

• Primary Sponsor: Medical corporation association Shizuyakai oozoranaika/hifuka
• Source(s) of Monetary Support: Mandom Corporation